Edition:
India

Alkermes And Clovis Oncology Initiate Research Collaboration To Explore Combination Cancer Therapies


Tuesday, 19 Feb 2019 

Feb 19 (Reuters) - Clovis Oncology Inc ::ALKERMES AND CLOVIS ONCOLOGY INITIATE RESEARCH COLLABORATION TO EXPLORE COMBINATION CANCER THERAPIES.CLOVIS ONCOLOGY- ALKERMES, CO TO EXAMINE COMBINATIONS OF ALKS 4230 WITH RUCAPARIB & ALKS 4230 WITH LUCITANIB IN MULTIPLE MODELS IN PRECLINICAL STUDIES.CLOVIS ONCOLOGY INC - COMPANIES WILL SHARE COSTS RELATED TO PRECLINICAL STUDIES. 

Company Quote

10.95
-0.62 -5.36%
19 Jul 2019